Zimmer Biomet Holdings (ZBH) EPS (Diluted) Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) EPS (Diluted) Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 18.07% |
| 10 | Zimmer Biomet Holdings | 19.29 Bn | 18.88 Bn | 1.54 Bn | 1.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.16% |
| Mar 31, 2026 | 3.24% |
| Mar 31, 2025 | 73.97% |
| Dec 31, 2024 | -168.00% |
| Sep 30, 2024 | 159.99% |
| Jun 30, 2024 | 378.99% |
| Mar 31, 2024 | 234.65% |
| Dec 31, 2023 | 1.07% |
| Sep 30, 2023 | -13.08% |
| Jun 30, 2023 | 44.12% |
| Mar 31, 2023 | 34.78% |
| Mar 31, 2022 | -30.72% |
| Dec 31, 2021 | 68.33% |
| Sep 30, 2021 | -28.06% |
| Jun 30, 2021 | -26.25% |
| Mar 31, 2021 | -70.39% |
| Dec 31, 2020 | 39.67% |
| Sep 30, 2020 | 34.57% |
| Jun 30, 2020 | -46.03% |
| Mar 31, 2020 | -54.29% |